North of England evidence based guidelines development project: Guideline for the primary care management of dementia

BMJ

Volumn 317, Issue 7161, 1998, Pages 802-

  Eccles, Martin ^a   Clarke, Julie ^b   Livingston, Moira ^c   Freemantle, Nick ^d   Mason, James ^d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIHYDROERGOTOXINE MESILATE; DONEPEZIL; TACRINE; VASODILATOR AGENT;

AFFECT; ANAMNESIS; BEHAVIOR; BEHAVIOR DISORDER; CAREGIVER; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FALLING; GENERAL PRACTICE; HUMAN; LEWY BODY; LIVER TOXICITY; MULTIINFARCT DEMENTIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESIDENTIAL CARE; REVIEW; SCREENING TEST; UNITED KINGDOM;

BEHAVIORAL SYMPTOMS; CAREGIVERS; DEMENTIA; DEPRESSION; EVIDENCE-BASED MEDICINE; FAMILY PRACTICE; HUMANS; PRACTICE GUIDELINES; WORKLOAD;

EID: 0032547521     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.317.7161.802     Document Type: Article

References (139)

1. North of England Evidence Based Guideline Development Project. Evidence based guideline for the primary care management of dementia. Newcastle upon Tyne: Centre for Health Services Research, 1998.
2. Eccles MP Clapp Z Grimshaw JM Adams PC Higgins B Purves I Russell IT. North of England evidence based guideline development project: methods of guideline development. BMJ 1996; 312: 760–761.
3. McCormick A Fleming D Charlton J. Morbidity statistics in general practice: fourth national study 1991-1992. London: HMSO, 1995 (Series MB5 No 3.)
4. Mowry BJ Burvill PW. A study of mild dementia in the community using a wide range of diagnostic criteria. Br J Psychiatry 1998; 153: 328–334.
5. O'Connor DW Pollitt PA Hyde JB Fellows JL Miller ND Roth M. A follow-up study of dementia diagnosed in the community using the Cambridge mental disorders of the elderly examination. Acta Psychiatr Scand 1990; 81: 78–82.
6. Tobiansky R Blizard R Livingston G Mann A. The Gospel Oak study stage IV: the clinical relevance of subjective memory impairment in older people. Psychol Med 1995; 25: 779–786.
7. Brayne C Gill C Huppert FA Barkley C Gehlhaar E Girling DM et al. Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge project for later life. Br J Psychiatry 1995; 17: 255–262.
8. McGlone J Gupta S Humphrey D Oppenheimer S Mirsen T Evans DR. Screening for early dementia using memory complaints from patients and relatives. Arch Neurol 1990; 47: 1189–1193.
9. Koss E Patterson MB Ownby R Stuckey JC Whitehouse PJ. Memory evaluation in Alzheimer's disease. Caregivers' appraisals and objective testing. Arch Neurol 1993; 50: 92–97.
10. Ship JA Puckett SA. Longitudinal study on oral health in subjects with Alzheimer's disease. J Am Geriatr Soc 1994; 42: 57–63.
11. Feher EP Larrabee GJ Sudilovsky A Crook 3rd TH. Memory self-report in Alzheimer's disease and in age-associated memory impairment. J Geriatr Psychiatr Neurol 1994; 7: 58–65.
12. McCormick WC Kukull WA van Belle G Bowen JD Teri L Larson EB. The effect of diagnosing Alzheimer's disease on frequency of physician visits: a case-control study. J Gen Intern Med 1995; 10: 187–193.
13. Bowers J Jorm AF Henderson S Harris P. General practitioners' detection of depression and dementia in elderly patients. Med J Aust 1990; 153: 192–196.
14. Cooper B Bickel H Schaufele M. The ability of general practitioners to detect dementia and cognitive impairment in their elderly patients: a study in Mannheim. Int J Geriatr Psychiatry 1992; 7: 591–598.
15. O'Connor DW Fertig A Grande MJ Hyde JB Perry JR Roland MO et al. Dementia in general practice: the practical consequences of a more positive approach to diagnosis. Br J Gen Pract 1993; 43: 185–188.
16. Erkinjuntti T Sulkava R Wikstrom J Autio L. Short portable mental status questionnaire as a screening test for dementia and delirium among the elderly. J Am Geriatr Soc 1987; 35: 412–416.
17. Sunderland T Hill JL Mellow AM Lawlor BA Gundersheimer J Newhouse PA et al. Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc 1989; 37: 725–729.
18. Gagnon M Letenneur L Dartigues JF Commenges D Orgogozo JM Barberger-Gateau P et al. Validity of the mini-mental state examination as a screening instrument for cognitive impairment and dementia in French elderly community residents. Neuroepidemiology 1990; 19: 143–150.
19. Galasko D Klauber MR Hofstetter CR Salmon DP Lasker B Thal LJ. The mini-mental state examination in the early diagnosis of Alzheimer's disease. Arch Neurol 1990; 47: 49–52.
20. Livingston G Sax K Willison J Blizard B Mann A. The Gospel Oak study stage II: the diagnosis of dementia in the community. Psychol Med 1990; 20: 881–891.
21. Kokmen E Smith GE Petersen RC Tangalos E Ivnik RC. The short test of mental status. Correlations with standardized psychometric testing. Arch Neurol 1991; 48: 725–728.
22. Jitapunkul S Pillay I Ebrahim S. The abbreviated mental test: its use and validity. Age Ageing 1991; 20: 332–336.
23. Uhlmann RF Larson EB. Effect of education on the mini-mental state examination as a screening test for dementia. J Am Geriatr Soc 1991; 39: 876–880.
24. Huntzinger JA Rosse RB Schwartz BL Ross LA Deutsch SI. Clock drawing in the screening assessment of cognitive impairment in an ambulatory care setting: a preliminary report. Gen Hosp Psychiatry 1992; 14: 142–144.
25. Wells JC Keyl PM Chase GA Aboraya A. Discriminant validity of a reduced set of mini-mental state examination items for dementia and Alzheimer's disease. Annual Scientific Meeting of the American Psychiatric Association (New Orleans, Louisiana). Acta Psychiatr Scand 1991; 86: 23–31.
26. Ylikoski R Erkinjuntti T Sulkava R Juva K Tilvis R Valvanne J. Correction for age, education and other demographic variables in the use of the mini-mental state examination in Finland. Acta Neurol Scand 1992; 85: 391–396.
27. Barberger-Gateau P Commenges D Gagnon M Letenneur L Sauvel C Dartigues JF. Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc 1992; 40: 1129–1134.
28. Mendez MF Ala T Underwood KL. Development of scoring criteria for the clock drawing task in Alzheimer's disease. J Am Geriatr Soc 1992; 40: 1095–1099.
29. Watson YI Arfken CL Birge SJ. Clock completion: an objective screening test for dementia. J Am Geriatr Soc 1993; 41: 1235–1240.
30. Wilcock GK Ashworth DL Langfield JA Smith PM. Detecting patients with Alzheimer's disease suitable for drug treatment: comparison of three methods of assessment [with comment]. Br J Gen Pract 1994; 44: 30–33.
31. Fillenbaum GG Wilkinson WE Welsh KA Mohs RC. Discrimination between stages of Alzheimer's disease with subsets of mini-mental state examination items. An analysis of consortium to establish a registry for Alzheimer's disease data. Arch Neurol 1994; 51: 916–921.
32. Troster AI Moe KE Vitiello MV Prinz PN. Predicting long-term outcome in individuals at risk for Alzheimer's disease with the dementia rating scale. J Neuropsychiatry Clin Neurosci 1994; 6: 54–57.
33. Iliffe S Mitchley S Gould I Haines A. Evaluation of the use of brief screening instruments for dementia, depression and problem drinking among elderly people in general practice. Br J Gen Pract 1994; 44: 503–507.
34. Braekhus A Laake K Engedal K. A low, ‘normal’ score on the mini-mental state examination predicts development of dementia after three years. J Am Geriatr Soc 1995; 43: 656–661.
35. Fox JH Topel JL Huckman MS. Dementia in the elderly: a search for treatable illnesses. J Gerontol 1975; 30: 557–564.
36. Delaney P. Dementia: the search for treatable causes. South Med J 1982; 75: 707–709.
37. Larson EB Reifler BV Sumi SM Canfield CG Chinn NM. Diagnostic tests in the evaluation of dementia. A prospective study of 200 elderly outpatients. Arch Intern Med 1986; 146: 1917–1922.
38. Kotsoris H Barclay LL Kheyfets S Hulyalkar A Dougherty J. Urinary and gait disturbances as markers for early multi-infarct dementia. Stroke 1987; 18: 138–141.
39. McIntyre L Frank J. Evaluation of the demented patient. J Fam Pract 1987; 24: 399–404.
40. Bayer AJ Pathy MS Twining C. The memory clinic. A new approach to the detection of early dementia. Drugs 1987; 33(Suppl 2): 84–89.
41. Kasa M Bierma TJ Waterstraat Jr F Corsaut M Singh SP. Routine blood chemistry screen: a diagnostic aid for Alzheimer's disease. Neuroepidemiology 1989; 8: 254–261.
42. Siu AL. Screening for dementia and investigating its causes. Ann Intern Med 1991; 115: 122–132.
43. Levitt AJ Karlinsky H. Folate, vitamin B12 and cognitive impairment in patients with Alzheimer's disease. Acta Psychiatr Scand 1992; 86: 301–305.
44. Richards M Stern Y Mayeux R. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology 1993; 43: 2184–2188.
45. Burke WJ McLaughlin JR Chung HD Gillespie KN Grossberg GT Luque FA et al. Occurrence of cancer in Alzheimer and elderly control patients: an epidemiologic necropsy study. Alzheimer Dis Associated Disord 1994; 8: 22–28.
46. McCormick WC Kukull WA van Belle G Bowen JD Teri L Larson EB. Symptom patterns and comorbidity in the early stages of Alzheimer's disease. J Am GeriatrSoc 1994; 42: 517–521.
47. Crystal HA Ortof E Frishman WH Gruber A Hershman D Aronson M. Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx longitudinal aging study. J Am Geriatr Soc 1994; 42: 933–936.
48. Clarnette RM Patterson CJ. Hypothyroidism: does treatment cure dementia? J Geriatr Psychiatry Neurol 1994; 7: 23–27.
49. McKeith I Fairbairn A Perry R Thompson P Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992; 305: 673–678.
50. McKeith IG Perry RH Fairbairn AF Jabeen S Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992; 22: 911–922.
51. Knesevich JW Martin RL Berg L Danziger W. Preliminary report on affective symptoms in the early stages of senile dementia of the Alzheimer type. Am J Psychiatry 1983; 140: 233–235.
52. Reding M Haycox J Blass J. Depression in patients referred to a dementia clinic. A three-year prospective study. Arch Neurol 1985; 42: 894–896.
53. Reifler BV Larson E Teri L Poulsen M. Dementia of the Alzheimer's type and depression. J Am Geriatr Soc 1986; 34: 855–859.
54. Lazarus LW Newton N Cohler B Lesser J Schweon C. Frequency and presentation of depressive symptoms in patients with primary degenerative dementia. Am J Psychiatry 1987; 144: 41–45.
55. Burke WJ Rubin EH Morris JC Berg L. Symptoms of “depression” in dementia of the Alzheimer type. Alzheimer Dis Associated Disord 1988; 2: 356–362.
56. Pearson JL Teri L Reifler BV Raskind MA. Functional status and cognitive impairment in Alzheimer's patients with and without depression. J Am Geriatr Soc 1989; 37: 1117–1121.
57. O'Connor DW Pollitt PA Roth M. Coexisting depression and dementia in a community survey of the elderly. Int Psychogeriatrics 1990; 2: 45–53.
58. Burns A Jacoby R Levy R. Psychiatric phenomena in Alzheimer's disease. III: Disorders of mood. Br J Psychiatry 1990; 157: 81–86.
59. Rosen J Zubenko GS. Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease. Biol Psychiatry 1991; 29: 224–232.
60. Passeri M Cucinotta D Abate G Senin U Ventura A Stramba Badiale M et al. Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Aging 1993; 5: 63–71.
61. Troisi A Pasini A Gori G Sorbi T Biagini C Aulisi A et al. Assessment of depression in Alzheimer's disease: symptoms, syndrome, and computed tomography findings. Dementia 1993; 4: 87–93.
62. Ballard CG Cassidy G Bannister C Mohan RN. Prevalence, symptom profile, and aetiology of depression in dementia sufferers. J Affect Disord 1993; 29: 1–6.
63. Fitz AG Teri L. Depression, cognition, and functional ability in patients with Alzheimer's disease. J Am Geriatr Soc 1994; 42: 186–191.
64. Verhey FR Ponds RW Rozendaal N Jolles J. Depression, insight, and personality changes in Alzheimer's disease and vascular dementia. J Geriatr Psychiatry Neurol 1995; 8: 23–27.
65. Burt DB Zembar MJ Niederehe G. Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol Bull 1995; 117: 285–305.
66. Speck CE Kukull WA Brenner DE Bowen JD McCormick WC Teri L et al. History of depression as a risk factor for Alzheimer's disease. Epidemiology 1995; 6: 366–369.
67. Ather SA Shaw SH Stoker MJ. A comparison of chlormethiazole and thioridazine in agitated confusional states of the elderly. Acta Psychiatr Scand 1986; 329(Suppl): 81–91.
68. Reisberg B Borenstein J Salob SP Ferris SH Franssen E Georgotas A. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987; 48 (Suppl): 9–15.
69. Lovett WC Stokes DK Taylor LB Young ML Free SM Phelan DG. Management of behavioral symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol. J Clin Psychiatry 1987; 48: 234–236.
70. Schneider LS Pollock VE Lyness SA. A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38: 553–563.
71. Deutsch LH Bylsma FW Rovner BW Steele C Folstein MF. Psychosis and physical aggression in probable Alzheimer's disease. Am J Psychiatry 1991; 148: 1159–1163.
72. Malone ML Thompson L Goodwin JS. Aggressive behaviors among the institutionalized elderly. J Am Geriatr Soc 1993; 41: 853–856.
73. Buchner DM Larson EB. Falls and fractures in patients with Alzheimer-type dementia. JAMA 1987; 20: 1492–1495.
74. Melton 3rd LJ Beard CM Kokmen E Atkinson EJ O'Fallon WM. Fracture risk in patients with Alzheimer's disease. J Am Geriatr Soc 1994; 42: 614–619.
75. Asada T Kariya T Kinoshita T Asaka A Morikawa S Yoshioka M et al. Predictors of fall-related injuries among community-dwelling elderly people with dementia. Age Ageing 1996; 25: 22–28.
76. Colerick EJ George LK. Predictors of institutionalization among caregivers of patients with Alzheimer's disease. J Am Geriatr Soc 1986; 34: 493–498.
77. Haley WE Levine EG Brown SL Bartolucci AA. Stress, appraisal, coping, and social support as predictors of adaptational outcome among dementia caregivers. Psychol Aging 1987; 2: 323–330.
78. Knopman DS Kitto J Deinard S Heiring J. Longitudinal study of death and institutionalization in patients with primary degenerative dementia. J Am Geriatr Soc 1988; 36: 108–112.
79. Steele C Rovner B Chase GA Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990; 147: 1049–1051.
80. Nygaard HA. Who cares for the caregiver? Factors exerting influence on nursing home admissions of demented elderly. Scand J Caring Sci 1991; 5: 157–162.
81. O'Donnell BF Drachman DA Barnes HJ Peterson KE Swearer JM Lew RA. Incontinence and troublesome behaviors predict institutionalization in dementia. J Geriatr Psychiatry Neurol 1992; 5: 45–52.
82. Collins C King S Kokinakis C. Community service issues before nursing home placement of persons with dementia. West J Nurs Res 1994; 16: 40–52.
83. Huang Y Macera CA Cornman CB Davis DR Scott WK Neff L. Survival of Alzheimer's disease patients with regard to pattern of care in South Carolina, 1988-1993. J SC Med Assoc 1994; 90: 51–55.
84. Lord TR Garner JE. Effects of music on Alzheimer patients. Perceptual Motor Skills 1993; 76: 451–455.
85. Tappen RM. The effect of skill training on functional abilities of nursing home residents with dementia. Res Nurs Health 1994; 17: 159–165.
86. Rovner BW Steele CD Shmuely Y Folstein MF. A randomized trial of dementia care in nursing homes. J Am Geriatr Soc 1996; 44: 7–13.
87. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81–106.
88. Meyer JS Rogers RL McClintic K Mortel KF Lotfi J. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study. J Am Geriatr Soc 1989; 37: 549–555.
89. Ratcliffe PJ Wilcock GK. Cerebrovascular disease in dementia: the importance of atrial fibrillation. Postgrad Med J 1985; 61: 201–204.
90. Kokmen E Beard CM Chandra V Offord KP Schoenberg BS Ballard DJ. Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 1991; 41: 1393–1397.
91. Tatemichi TK Desmond DW Mayeux R Paik M Stern Y Sano M et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992; 42: 1185–1193.
92. Hughes JR Williams JG Currier RD. An ergot alkaloid preparation (hydergine) in the treatment of dementia: critical review of the clinical literature. J Am Geriatr Soc 1976; 24: 490–497.
93. McDonald RJ. Hydergine: a review of 26 clinical studies. Pharmakopsychiatrie Neuro-Psychopharmakologie 1979; 12: 407–422.
94. Venn RD. Review of clinical studies with ergots in gerontology. Adv Biochem Psychopharmacol 1980; 23: 363–377.
95. Van Loveren-Huyben CM Engelaar HF Hermans MB van der Bom JA Leering C Munnichs JM. Double-blind clinical and psychologic study of ergoloid mesylates (hydergine) in subjects with senile mental deterioration. J Am Geriatr Soc 1984; 32: 584–588.
96. Thompson 2nd TL Filley CM Mitchell WD Culig KM LoVerde M Byyny RL. Lack of efficacy of hydergine in patients with Alzheimer's disease. N Engl J Med 1990; 323: 445–448 1990; 323:691.]
97. Yesavage JA Tinklenberg JR Hollister LE Berger PA. Vasodilators in senile dementias: a review of the literature. Arch Gen Psychiatry 1979; 36: 220–223.
98. Autuono PG, for the Mentane Study Group. Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. Arch Intern Med 1995; 155: 1766–1772.
99. Chatellier G Lacomblez L, on behalf of Groupe Français d'Etude de la Tetrahydroaminoacrideine. Tacrine (tetrahyroaminoacridine: THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. BMJ 1990; 300: 495–499.
100. Davis KL Thal LJ Gamzu ER Davis CS Woolson RF Gracon SI et al. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. N Engl J Med 1992; 327: 1253–1259.
101. Eagger SA Levy R Sahakian BJ. Tacrine in Alzheimer's disease. Lancet 1991; 337: 989–992.
102. Farlow M Gracon SI Hershey LA Lewis KW Wadowsky CH Dolan Ureno J et al. A controlled trial of tacrine in Alzheimer's Disease. JAMA 1992; 268: 2523–2529.
103. Forette F Hoover T Gracon S de Rotrou J Hervy MP Lechevalier B et al. A double-blind, placebo-controlled, enriched population study of tacrine in patients with Alzheimer's disease. Eur J Neurol 1995; 2: 229–238
104. Gauthier S Bouchard R Lamontagne A Bailey P Bergman H Ratner J et al. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease: results of a Canadian double-blind, crossover, multicenter study. N Engl J Med 1990; 322: 1272–1276.
105. Knapp MJ Knopman DS Solomon PR Pendlebury WW Davis CS Gracon SI et al. A 30-week randomized controlled trial of high dose tacrine in patients with Alzheimer's disease. JAMA 1994; 271: 985–991.
106. Maltby N Broe A Creasey H Jorm AF Christensen H Brooks WS. Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: a double blind trial. BMJ 1994; 308: 879–883.
107. Molloy DW Guyatt GH Wilson DB Duke R Rees L Singer J. Effect of tetrahydroaminoacridine on cognition, function and behaviour in Alzheimer's disease. Can Med Assoc J 1991; 144: 29–34.
108. Murphy MF Hardiman ST Nash RJ Huff FJ Demkovitch JJ Dobson C et al. Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease. Ann NY Acad Sci 1991; 640: 253–262.
109. Nybäck H Hassan M Junthé Áhlin A. Clinical experiences and biochemical findings with tacrine (THA). Acta Neurol Scand 1993; 149(Suppl): 36–38.
110. Watkins PB Zimmerman HJ Knapp MJ Gracon SI Lewis KW. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 1994; 271: 992–998.
111. Wood PC Castleden CM. A double-blind, placebo controlled, multicentre study of tacrine for Alzheimer's disease. Int J Geriatr Psychiatry 1994; 9: 649–654.
112. A preliminary, multicenter, randomised, double blind, placebo controlled evaluation of the safety and efficacy of E2020 in patients with Alzheimer's disease. London: Eisai Ltd, 1995(Study report of E2020 phase II dose ranging study, protocol E2020-A001-201. Ind no 35,974)
113. A 15-week, multicenter, randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of E2020 in patients with Alzheimer's disease. London: Eisai Ltd., 1996(Study report of E2020 phase III 15-week, double-blind study, protocol E2020 -A001-301. Ind no 35,974)
114. A 30-week,multicenter, randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of E2020 in patients with Alzheimer's disease. London: Eisai Ltd, 1996 (Study report of E2020 Phase III 30-week, double-blind study protocol E2020-A001-302. Ind no 35,974)
115. Rogers SL Friedhoff LT and the Donepezil Study Group. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre randomized, double blind, placebo-controlled trial. Dementia 1996; 7: 293–303.
116. Rogers SL Doody RS Mohs RC Friedhof LT and the Donepezil Study Group. Donepzil improves cognition and global function in Alzheimer's disease. A 15 week, double blind, placebo controlled study. Arch Intern Med 1998; 158: 1021–1031.
117. Hanley IG McGuire RJ Boyd WD. Reality orientation and dementia: a controlled trial of two approaches. Br J Psychiatry 1981; 138: 10–14.
118. Haley WE Levine EG Brown SL Berry JW Hughes GH. Psychological, social, and health consequences of caring for a relative with senile dementia. J Am Geriatr Soc 1987; 35: 405–411.
119. Zarit SH Anthony CR Boutselis M. Interventions with care givers of dementia patients: comparison of two approaches. Psychol Aging 1987; 2: 225–232.
120. Lawton MP Brody EM Saperstein AR. A controlled study of respite service for caregivers of Alzheimer's patients. Gerontologist 1989; 29: 8–16.
121. Brodaty H Gresham M. Effect of a training programme to reduce stress in carers of patients with dementia. BMJ 1989; 299: 1375–1379.
122. Morris LW Morris RG Britton PG. Cognitive style and perceived control in spouse caregivers of dementia sufferers. Br J Med Psychol 1989; 62: 173–179.
123. Gallagher D Rose J Rivera P Lovett S Thompson LW. Prevalence of depression in family caregivers. Gerontologist 1989; 29: 449–456.
124. Engedal K. Day care for demented patients in general nursing homes. Effects on admissions to institutions and mental capacity. Scand J Prim Health Care 1989; 7: 161–166.
125. Goodman CC Pynoos J. A model telephone information and support program for caregivers of Alzheimer's patients. Gerontologist 1990; 30: 399–404.
126. Dura JR Stukenberg KW Kiecolt-Glaser JK. Anxiety and depressive disorders in adult children caring for demented parents. Psychol Aging 1991; 6: 467–473.
127. Schulz R Williamson GM. A 2-year longitudinal study of depression among Alzheimer's caregivers. Psychol Aging 1991; 6: 569–578.
128. Haley WE Clair JM Saulsberry K. Family caregiver satisfaction with medical care of their demented relatives. Gerontologist 1992; 32: 219–226.
129. Wimo A Mattsson B Adolfsson R Eriksson T Nelvig A. Dementia day care and its effects on symptoms and institutionalization: a controlled Swedish study. Scand J Prim Health Care 1993; 11: 117–123.
130. Mittelman MS Ferris SH Steinberg G Shulman E Mackell JA Ambinder A et al. An intervention that delays institutionalization of Alzheimer's disease patients: treatment of spouse-caregivers. Gerontologist 1993; 33: 730–740.
131. Williams GO Gjerde CL Haugland S Darnold D Simonton LJ Woodward PJ. Patients with dementia and their caregivers 3 years after diagnosis. A longitudinal study. Arch Fam Med 1995; 4: 512–517.
132. Ballard CG Saad K Coope B Graham C Gahir M Wilcock GK et al. The aetiology of depression in the carers of dementia sufferers. J Affect Disord 1995; 35: 59–63.
133. Hébert R Girouard D Leclerc G Bravo G. The impact of a support group programme for care-givers on the institutionalisation of demented patients. Arch Gerontol Geriatr 1995; 20: 129–134.
134. Zarit SH Todd PA Zarit JM. Subjective burden of husbands and wives as caregivers: a longitudinal study. Gerontologist 1986; 26: 260–266.
135. Haley WE Pardo KM. Relationship of severity of dementia to caregiving stressors. Psychol Aging 1989; 4: 389–392.
136. Stephens MA Kinney JM Ogrocki PK. Stressors and well-being among caregivers to older adults with dementia: the in-home versus nursing home experience. Gerontologist 1991; 31: 217–223.
137. Vitaliano PP Russo J Young HM Teri L Maiuro RD. Predictors of burden in spouse caregivers of individuals with Alzheimer's disease. Psychol Aging 1991; 6: 392–402.
138. Parks SH Pilisuk M. Caregiver burden: gender and the psychological costs of caregiving. Am J Orthopsychiatry 1991; 61: 501–509.
139. Russo J Vitaliano PP. Life events as correlates of burden in spouse caregivers of persons with Alzheimer's disease. Exp Aging Res 1995; 21: 273–294.